Welcome to our dedicated page for Precision Optics SEC filings (Ticker: POCI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Precision Optics Corporation, Inc. (NASDAQ: POCI), a vertically integrated optics company serving healthcare and defense/aerospace markets. Although specific filings are not listed here, POCI’s reports on EDGAR typically include annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, along with other required disclosures.
Through these filings, Precision Optics presents detailed information about its business, which centers on proprietary micro-optics, 3D imaging and digital imaging technologies. The company describes how it supports medical device and defense/aerospace customers from new product concept through mass manufacture, including engineering and production revenue streams, facility expansions and risk factors related to demand, supply chains and economic conditions.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain key sections of lengthy filings in plain language. For example, users can quickly see how management discusses trends in engineering versus production revenue, how non-GAAP measures such as Adjusted EBITDA are reconciled to GAAP results, and how the company characterizes its exposure to healthcare and defense/aerospace markets.
Investors can use this page to monitor new 10-K and 10-Q filings as they are posted to EDGAR in real time, as well as any 8-K current reports that may describe material events such as new development agreements, facility moves or changes in capital structure. Where applicable, insider transaction reports on Form 4 and proxy statements on Schedule 14A can also be reviewed to understand equity compensation practices and ownership changes.
By combining official SEC documents for POCI with AI-generated insights, this page helps users navigate complex regulatory filings and focus on the disclosures most relevant to Precision Optics’ optical instrument business.
Precision Optics Corporation (POCI) filed Amendment No. 1 to its Annual Report to include Items 10–14 of Part III after determining it would not file a definitive proxy within 120 days of fiscal year-end. The amendment updates directors and executive officers, governance practices, executive and director compensation, beneficial ownership, and auditor fees, and adds new Section 302 officer certifications.
No financial statements are included, and Section 906 certifications are not required for this amendment. Board changes include the appointments of Buell G. Duncan on February 28, 2025 and Joseph P. Pellegrino, Jr. on March 19, 2025, and the resignations of Dr. Richard B. Miles on February 28, 2025 and Peter V. Anania on March 14, 2025. Compensation updates include a bonus of 20,000 shares to the CEO valued at $94,200 at $4.71 per share and option grants (CEO 200,000; CFO 50,000; COO 40,000, subject to forfeiture upon departure on October 31, 2025). Shares outstanding were 7,714,701 as of September 20, 2025. Audit fees totaled $173,746 for the year ended June 30, 2025.
Precision Optics Corporation, Inc. (POCI) filed a Form 10-K reporting fiscal year results and disclosures for the year ended June 30, 2025. The company disaggregates revenue by two segments: Systems Manufacturing with $8,290,225 and MicroOptics Lab with $2,135,562. The consolidated results show a significant operating loss of $5,551,291 and a loss before income taxes of $5,778,310. Stockholders' equity reflects 7,714,701 shares outstanding at June 30, 2025.
Liquidity and financing actions are highlighted: net proceeds from a registered direct offering in August 2024 were approximately $1.2 million and an unregistered placement in February 2025 generated gross proceeds of approximately $5.1 million. Contract liabilities increased to $1,773,735 from $405,278. Long-term debt, net of current maturities, is reported as $1,289,205, and certain debt covenants required an equity raise of at least $4.5 million, which the company satisfied on February 21, 2025.